Ginkgo Bioworks Holdings DNA
NYSE DNA
$12.49 -0.34 (-2.65%)
As of: Oct 1, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Preferred Stock Liabilities (2021)

Updated

Ginkgo Bioworks Holdings' Preferred Stock Liabilities was $1.47 billion in Q2 2021, down 6.8% from the prior quarter.

Analysis

Ginkgo Bioworks Holdings (DNA) Preferred Stock Liabilities (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Iqvia Holdings 44.26 Bn 36.10 Bn 1.44 Bn -
2 Medpace Holdings 17.42 Bn 15.48 Bn 201.64 Mn -
3 Charles River Laboratories International 14.08 Bn 13.32 Bn 363.37 Mn -
4 Icon 13.02 Bn 10.12 Bn 479.29 Mn -
5 Fortrea Holdings 1.90 Bn 1.28 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 817.41 Mn 55.33 Mn 18.44 Mn -
7 Evotec SE 608.00 Mn -965.22 Mn - -
8 Champions Oncology 69.59 Mn 45.24 Mn 7.70 Mn -
9 MindWalk Holdings 62.13 Mn 26.34 Mn 1.61 Mn -
10 Natural Alternatives International 8.98 Mn -19.10 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 1.47 Bn
Mar 31, 2021 1.57 Bn
API Access

Ginkgo Bioworks Holdings Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=DNA&period=max&api_key=YOUR_API_KEY